Abbott Laboratories
ABT
#74
Rank
S$281.91 B
Marketcap
S$161.98
Share price
-0.26%
Change (1 day)
5.99%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

Abbott Laboratories (ABT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$42.62 Billion

According to Abbott Laboratories's latest financial reports the company's total liabilities are S$42.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abbott Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$45.55 B0.3%
2023-12-31S$45.41 B-9.74%
2022-12-31S$50.31 B-4.99%
2021-12-31S$52.95 B1.23%
2020-12-31S$52.31 B6.06%
2019-12-31S$49.32 B-0.95%
2018-12-31S$49.79 B-17.54%
2017-12-31S$60.39 B30.6%
2016-12-31S$46.23 B64.09%
2015-12-31S$28.17 B8.98%
2014-12-31S$25.85 B15.39%
2013-12-31S$22.40 B-54.67%
2012-12-31S$49.43 B6.77%
2011-12-31S$46.29 B-4.93%
2010-12-31S$48.70 B17.52%
2009-12-31S$41.44 B16.37%
2008-12-31S$35.61 B12.82%
2007-12-31S$31.56 B-6.96%
2006-12-31S$33.92 B38.36%
2005-12-31S$24.51 B4.07%
2004-12-31S$23.56 B6.94%
2003-12-31S$22.03 B-6.6%
2002-12-31S$23.58 B-10.5%
2001-12-31S$26.35 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$147.03 B 244.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.74 B 251.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$67.16 B 57.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$5.13 B-87.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$55.47 B 30.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Bristol-Myers Squibb
BMY
S$101.38 B 137.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
S$24.70 B-42.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$88.68 B 108.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$80.98 B 89.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
S$79.36 B 86.18%๐Ÿ‡ฌ๐Ÿ‡ง UK